Institute for Policy Innovation Opposes IPI: Problems With a Prescription Drug Pricing Index
July 25, 2020
July 25, 2020
DALLAS, Texas, July 25 -- The Institute for Policy Innovation issued the following news release:
The Institute for Policy Innovation (IPI), a 33 year-old free market public policy research organization, released this statement in opposition to the Trump administration's International Pricing Indexing (IPI) plan for prescription drugs:
President Donald Trump reportedly plans to sign an executive order setting up an International Pricing Index for certain prescription dr . . .
The Institute for Policy Innovation (IPI), a 33 year-old free market public policy research organization, released this statement in opposition to the Trump administration's International Pricing Indexing (IPI) plan for prescription drugs:
President Donald Trump reportedly plans to sign an executive order setting up an International Pricing Index for certain prescription dr . . .